Clinical Trial Update: Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HLX22 combined with trastuzumab and chemotherapy versus placebo with trastuzumab and chemotherapy for locally advanced or meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HLX22
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Gastric Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING